Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol ▲ | Gene ID | Gene Name | UniProt ID |
|---|---|---|---|---|---|
| C1956346 | Coronary Artery Disease | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
| C0027726 | Nephrotic Syndrome | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
| C0019187 | Hepatitis, Alcoholic | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
| C0948008 | Ischemic stroke | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
| C0015652 | Fascioliasis | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
| C3887494 | ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
| C1168401 | Squamous cell carcinoma of the head and neck | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
| C1565489 | Renal Insufficiency | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
| C0027404 | Narcolepsy | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
| C0019189 | Hepatitis, Chronic | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
| C0011265 | Presenile dementia | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
| C0162557 | Liver Failure, Acute | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
| C1306459 | Primary malignant neoplasm | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
| C1847593 | EPIPHYSEAL DYSPLASIA, MULTIPLE, 4 | SLC26A2 | 1836 | solute carrier family 26 member 2 | P50443 |
| C1850555 | De La Chapelle Dysplasia | SLC26A2 | 1836 | solute carrier family 26 member 2 | P50443 |
| C0265274 | Achondrogenesis, type IB (disorder) | SLC26A2 | 1836 | solute carrier family 26 member 2 | P50443 |
| C1384666 | hearing impairment | SLC26A2 | 1836 | solute carrier family 26 member 2 | P50443 |
| C1850554 | Atelosteogenesis type 2 | SLC26A2 | 1836 | solute carrier family 26 member 2 | P50443 |
| C0220726 | Diastrophic dysplasia | SLC26A2 | 1836 | solute carrier family 26 member 2 | P50443 |
| C0029422 | Osteochondrodysplasias | SLC26A2 | 1836 | solute carrier family 26 member 2 | P50443 |
| C3495559 | Juvenile arthritis | SLC26A2 | 1836 | solute carrier family 26 member 2 | P50443 |
| C0025500 | Mesothelioma | SLC26A2 | 1836 | solute carrier family 26 member 2 | P50443 |
| C0026760 | Multiple Epiphyseal Dysplasia | SLC26A2 | 1836 | solute carrier family 26 member 2 | P50443 |
| C1306459 | Primary malignant neoplasm | SLC26A2 | 1836 | solute carrier family 26 member 2 | P50443 |
| C0013604 | Edema | SLC26A2 | 1836 | solute carrier family 26 member 2 | P50443 |
